NCT01743131 2025-12-11Abatacept as GVHD Prophylaxis Phase 2Boston Children's HospitalPhase 2 Completed186 enrolled 14 charts 1 FDA
NCT03680092 2025-10-02Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell TransplantationUniversity of California, San DiegoPhase 2 Completed43 enrolled 10 charts
NCT03457142 2025-03-04Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to ChemotherapyRoswell Park Cancer InstitutePhase 2 Terminated15 enrolled 12 charts
NCT01012492 2019-11-21Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCTBoston Children's HospitalPhase 2 Completed11 enrolled 10 charts